✦ LIBER ✦

O-6 Phase II randomized trial of irinotecan/docetaxel (ID) or irinotecan/gemcitabine (IG) with or without celecoxib in second-line non-small cell lung cancer (NSCLC) — preliminary results

✍ Scribed by Lilenbaum, Rogerio; Bonomi, Philip; Socinski, Mark Anthony

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PD-076 Phase II randomized trial of irin

✍ Lilenbaum, R.; Socinski, M.; Altorki, N.; Hart, L.; Keresztes, R.; Hariharan, S. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 126 KB

6579 POSTER Randomized phase II trial of

✍ Kinoshita, A.; Fukuda, M.; Nagashima, S.; Fukuda, M.; Takatani, H.; Nakano, H.; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Docetaxel/gemcitabine or cisplatin/gemci

✍ D. Binder; H. Schweisfurth; C. Grah; C. Schäper; B. Temmesfeld-Wollbrück; G. Sie 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 340 KB

Preliminary results of a phase II random

✍ Marangolo, M; Cognetti, F; Di Costanzo, F; Selvaggi, G; Scagliotti, G.V 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 140 KB

O-110 Preliminary results of a phase II

✍ Gadgeel, Shirish M.; Shehadeh, Nasfet; Kraut, Michael J.; Wozniak, Antoinette; B 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB

O-53 A randomized phase II trial of gemc

✍ Leong, Swan Swan; Fool, Kian Fong; Tay, Miah Hiang; Toh, Chee Keong; Lim, Darren 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 359 KB